BIOCRYST PHARMACEUTICALS INC 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Apr 29, 2004
Insider Transaction Report
Form 4
BUGG CHARLES E
DirectorChairman
Transactions
- Sale
Common Stock
2004-04-27$9.55/sh−7,500$71,657→ 52,557 total - Sale
Common Stock
2004-04-27$9.55/sh−10,000$95,500→ 60,057 total - Award
Common Stock
2004-04-27$4.63/sh+100,000$462,500→ 137,557 total - Exercise/Conversion
Stock Option
2004-04-27−100,000→ 558,901 totalExercise: $4.63From: 1995-12-09Exp: 2004-12-08→ Common Stock (100,000 underlying) - Sale
Common Stock
2004-04-27$9.50/sh−67,500$641,250→ 70,057 total
Holdings
- 73,138(indirect: By Partnership)
Common Stock